April 1, 20240 citationsOpen Access

Supplemental Figure 3 from Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax

Key points are not available for this paper at this time.

Supplemental Figure 3: Overall survival and event-free survival in CMML.

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Bazinet et al. (Mon,) studied this question.

Perguntar à IA

Bookmark

View Full Paper